GlassScriptPhysician profile
Riaz N Chaudhary
NPI 1912904236
$1,447.10
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $93.75 · 2021: $320 · 2022: $440 · 2023: $238 · 2024: $34.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $344.24 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $327.69 | 2019-2023 | |
| Abbvie INC. | $104.69 | 2019-2024 | |
| Novo Nordisk INC | $91.92 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $70.24 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.80 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $48.44 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $47.85 | 2019-2023 | Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.76 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $32.31 | 2021-2022 | |
| Lundbeck LLC | $29.30 | 2023 | Rexulti |
| Merck Sharp & Dohme LLC | $28.81 | 2019-2022 | |
| Axsome Therapeutics, INC. | $28.52 | 2022-2023 | Sunosi |
| Astrazeneca Pharmaceuticals LP | $26.03 | 2019-2022 | |
| Amgen INC. | $18.84 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $18.48 | 2020 | |
| Insmed, INC. | $17.15 | 2021 | |
| Electromed, INC. | $16.44 | 2024 | Smartvest |
| Glaxosmithkline, LLC. | $15.84 | 2023 | Trelegy Ellipta |
| Abbott Laboratories | $15.77 | 2022 | |
| Horizon Therapeutics Plc | $15.14 | 2021 | |
| Ironshore Pharmaceuticals INC. | $15.00 | 2020 | |
| Becton, Dickinson and Company | $14.09 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riaz Chaudhary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.